Renhe Pharmacy Co.,Ltd (SHE:000650)

Market Cap	7.82B
Revenue (ttm)	3.82B
Net Income (ttm)	468.92M
Shares Out	1.38B
EPS (ttm)	0.34
PE Ratio	16.81
Forward PE	n/a
Dividend	0.15 (2.65%)
Ex-Dividend Date	Jul 8, 2024

Volume	26,277,810
Average Volume	15,983,229
Open	5.51
Previous Close	5.58
Day's Range	5.51 - 5.69
52-Week Range	5.10 - 7.03
Beta	0.59
RSI	64.33
Earnings Date	Aug 25, 2025

About Renhe Pharmacy Co.,Ltd

Renhe Pharmacy Co.,Ltd produces and sells pharmaceutical products. It offers Chinese and western medicines and raw materials; and health-related products, including oral solid preparations and liquid preparations, large-volume and small-volume injections, external lotions, liniments, suppositories, ointments, and other dosage forms of drugs and health-related products. The company was founded in 1996 and is headquartered in Nanchang, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1996
• Employees: 5,394
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000650

Financial Performance

In 2024, Renhe Pharmacy Co.,Ltd's revenue was 4.07 billion, a decrease of -19.02% compared to the previous year's 5.03 billion. Earnings were 481.91 million, a decrease of -15.05%.